Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Revised terminal half-life of nonacog alfa as derived from extended sampling data: A real-world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis.
Tardy B, Lambert T, Chamouni P, Montmartin A, Trossaert M, Claeyssens S, Berger C, Ardillon L, Gay V, Delavenne X, Harroche A, Chelle P. Tardy B, et al. Among authors: chamouni p. Haemophilia. 2022 Jul;28(4):542-547. doi: 10.1111/hae.14560. Epub 2022 Apr 14. Haemophilia. 2022. PMID: 35420242
Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study.
Bauduer F, de Raucourt E, Boyer-Neumann C, Trossaert M, Beurrier P, Faradji A, Peynet J, Borg JY, Chamouni P, Chatelanaz C, Henriet C, Bridey F, Goudemand J; French Postmarketing Study Group. Bauduer F, et al. Among authors: chamouni p. Haemophilia. 2015 Jul;21(4):481-9. doi: 10.1111/hae.12655. Epub 2015 Mar 26. Haemophilia. 2015. PMID: 25817556 Free PMC article.
Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): study protocol for a multicentric French national observational cross-sectional study.
Resseguier N, Rosso-Delsemme N, Beltran Anzola A, Baumstarck K, Milien V, Ardillon L, Bayart S, Berger C, Bertrand MA, Biron-Andreani C, Borel-Derlon A, Castet S, Chamouni P, Claeyssens Donadel S, De Raucourt E, Desprez D, Falaise C, Frotscher B, Gay V, Goudemand J, Gruel Y, Guillet B, Harroche A, Hassoun A, Huguenin Y, Lambert T, Lebreton A, Lienhart A, Martin M, Meunier S, Monpoux F, Mourey G, Negrier C, Nguyen P, Nyombe P, Oudot C, Pan-Petesch B, Polack B, Rafowicz A, Rauch A, Rivaud D, Schneider P, Spiegel A, Stoven C, Tardy B, Trossaërt M, Valentin JB, Vanderbecken S, Volot F, Voyer-Ebrard A, Wibaut B, Leroy T, Sannie T, Chambost H, Auquier P. Resseguier N, et al. Among authors: chamouni p. BMJ Open. 2018 Jul 25;8(7):e022409. doi: 10.1136/bmjopen-2018-022409. BMJ Open. 2018. PMID: 30049701 Free PMC article.
Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort.
Bouttefroy S, Meunier S, Milien V, Boucekine M, Chamouni P, Desprez D, Harroche A, Hochart A, Thiercelin-Legrand MF, Wibaut B, Chambost H, Rugeri L; CoDeC study group. Bouttefroy S, et al. Among authors: chamouni p. Br J Haematol. 2020 Jan;188(2):317-320. doi: 10.1111/bjh.16133. Epub 2019 Aug 14. Br J Haematol. 2020. PMID: 31414482 Free article. Review.
Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?
Allard Q, Djerada Z, Pouplard C, Repessé Y, Desprez D, Galinat H, Frotscher B, Berger C, Harroche A, Ryman A, Flaujac C, Chamouni P, Guillet B, Volot F, Szymezak J, Nguyen P, Cazaubon Y. Allard Q, et al. Among authors: chamouni p. Pharmaceutics. 2020 Apr 21;12(4):380. doi: 10.3390/pharmaceutics12040380. Pharmaceutics. 2020. PMID: 32326156 Free PMC article.
Management of von Willebrand disease with a factor VIII-poor von Willebrand factor concentrate: Results from a prospective observational post-marketing study.
Goudemand J, Bridey F, Claeyssens S, Itzhar-Baïkian N, Harroche A, Desprez D, Négrier C, Chamouni P, Chambost H, Henriet C, Susen S, Borel-Derlon A. Goudemand J, et al. Among authors: chamouni p. J Thromb Haemost. 2020 Aug;18(8):1922-1933. doi: 10.1111/jth.14928. Epub 2020 Jun 25. J Thromb Haemost. 2020. PMID: 32445594 Free PMC article.
Gastrointestinal bleeding from angiodysplasia in von Willebrand disease: Improved diagnosis and outcome prediction using videocapsule on top of conventional endoscopy.
Rauch A, Paris C, Repesse Y, Branche J, D'Oiron R, Harroche A, Ternisien C, Castet SM, Lebreton A, Pan-Petesch B, Volot F, Claeyssens S, Chamouni P, Gay V, Berger C, Desprez D, Falaise C, Biron Andreani C, Marichez C, Pradines B, Zawadzki C, Itzhar Baikian N, Borel-Derlon A, Goudemand J, Gerard R, Susen S; French Reference Center on von Willebrand Disease. Rauch A, et al. Among authors: chamouni p. J Thromb Haemost. 2021 Feb;19(2):380-386. doi: 10.1111/jth.15155. Epub 2020 Nov 29. J Thromb Haemost. 2021. PMID: 33113216 Free article.
Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment Centres.
Gautier P, Guillet B, Sigaud M, Claeyssens S, Volot FG, Chamouni P, Lienahrt A, Frotscher B, Fournel A, Castet S, Poumayou C, Gay V, Thuret R, Wibaut B, Biron-Andreani C. Gautier P, et al. Among authors: chamouni p. Haemophilia. 2022 May;28(3):437-444. doi: 10.1111/hae.14507. Epub 2022 Feb 24. Haemophilia. 2022. PMID: 35201650
Effectiveness of long-term prophylaxis using pdFVIII/VWF concentrate in patients with inherited von Willebrand disease.
Rugeri L, Harroche A, Repessé Y, Desprez D, Petesch BP, Chamouni P, Biron C, Frotscher B, Catovic H, Bracquart D, Martin C, Trossaërt M, Meunier S, d'Oiron R. Rugeri L, et al. Among authors: chamouni p. Eur J Haematol. 2022 Jul;109(1):109-117. doi: 10.1111/ejh.13778. Epub 2022 Apr 29. Eur J Haematol. 2022. PMID: 35438801 Free PMC article.
39 results